<DOC>
	<DOCNO>NCT00808392</DOCNO>
	<brief_summary>This study investigate safety immunogenicity monovalent conjugate vaccine Haemophilus influenzae type b healthy child age 2 4 month China .</brief_summary>
	<brief_title>Safety Immunogenicity Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Haemophilus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Infants either sex , age 2 4 month In good health determine : medical history physical examination clinical judgment investigator ; Available visit schedule study able comply study regulation For write informed consent obtain least one parent legal guardian Parent legal guardian unwilling unable give write informed consent participate study Infants receive Haemophilus influenzae type b immunization dose Infants present previous disease potentially related Haemophilus influenzae type b Infants household contact and/or intimate exposure previous 30 day individual ascertain Haemophilus influenzae type b disease Premature ( 37th week gestation ) birth weight less 2500 g History anaphylactic shock , asthma , urticaria allergic reaction previous vaccination hypersensitivity vaccine component Fever ≥ 38.0 °C ( axillary body temperature ) or/and significant acute chronic infection require systemic antibiotic antiviral therapy within past 7 day enrollment Subjects serious chronic disease cardiac , neurological , metabolic , hematologic , neoplastic disease Known/suspected immunodeficiency , autoimmune disease , immunologic disorder Subjects neurological disorder , e.g. , epilepsy history seizure disorder Subjects clinically significant genetic anomaly Treatment corticosteroid immunosuppressive drug Any previous treatment parenteral immunoglobulin preparation , blood product , and/or plasma derivative Any vaccination administer within one week ( 7 day ) enrollment and/ plan administration vaccine outside Chinese routine vaccination program . Participation investigational trial simultaneously Planned surgery study period Any condition , , opinion investigator , might interfere evaluation study objective</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>4 Months</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>vaccine</keyword>
	<keyword>prevention</keyword>
	<keyword>haemophilus influenzae type b</keyword>
	<keyword>child</keyword>
</DOC>